186 related articles for article (PubMed ID: 6927543)
1. Pharmacokinetics of oral and intravenous indomethacin in preterm infants.
Bhat R; Vidyasagar D; Fisher E; Hastreiter A; Ramirez JL; Burns L; Evans M
Dev Pharmacol Ther; 1980; 1(2-3):101-10. PubMed ID: 6927543
[TBL] [Abstract][Full Text] [Related]
2. A comparison of oral and intravenous indomethacin dispositions in the premature infant with patent ductus arteriosus.
Evans M; Bhat R; Vidyasagar D; Patel M; Hastreiter A
Pediatr Pharmacol (New York); 1981; 1(3):251-8. PubMed ID: 7346745
[TBL] [Abstract][Full Text] [Related]
3. Orogastric and intravenous indomethacin administration to very premature neonates with patent ductus arteriosus: population pharmacokinetics, absolute bioavailability, and treatment outcome.
Al Za'abi M; Donovan T; Tudehope D; Woodgate P; Collie LA; Charles B
Ther Drug Monit; 2007 Dec; 29(6):807-14. PubMed ID: 18043480
[TBL] [Abstract][Full Text] [Related]
4. Is oral indomethacin effective in treatment of preterm infants with patent ductus arteriosus?
Satar M; Yapicioğlu H; Narli N; Ozbarlas N; Küçükosmanoğlu O; Tutak E
Turk J Pediatr; 2004; 46(2):137-41. PubMed ID: 15214742
[TBL] [Abstract][Full Text] [Related]
5. A comparison of oral ibuprofen and intravenous indomethacin for closure of patent ductus arteriosus in preterm infants.
Chotigeat U; Jirapapa K; Layangkool T
J Med Assoc Thai; 2003 Aug; 86 Suppl 3():S563-9. PubMed ID: 14700149
[TBL] [Abstract][Full Text] [Related]
6. Oral ibuprofen and indomethacin for treatment of patent ductus arteriosus in premature infants: a randomized trial at Ramathibodi Hospital.
Supapannachart S; Limrungsikul A; Khowsathit P
J Med Assoc Thai; 2002 Nov; 85 Suppl 4():S1252-8. PubMed ID: 12549803
[TBL] [Abstract][Full Text] [Related]
7. Effects of indomethacin on digoxin pharmacokinetics in preterm infants.
Koren G; Zarfin Y; Perlman M; MacLeod SM
Pediatr Pharmacol (New York); 1984; 4(1):25-30. PubMed ID: 6739184
[TBL] [Abstract][Full Text] [Related]
8. Comparison of oral ibuprofen and indomethacin therapy for patent ductus arteriosus in preterm infants.
Fakhraee SH; Badiee Z; Mojtahedzadeh S; Kazemian M; Kelishadi R
Zhongguo Dang Dai Er Ke Za Zhi; 2007 Oct; 9(5):399-403. PubMed ID: 17937843
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of indomethacin in the premature infant.
Bianchetti G; Monin P; Marchal F; Dubruc C; Boutroy MJ; Morselli PL; Vert P
Dev Pharmacol Ther; 1980; 1(2-3):111-24. PubMed ID: 6927544
[TBL] [Abstract][Full Text] [Related]
10. [Patent ductus arteriosus in premature newborns. Treatment with indomethacin (author's transl)].
Marchal F; Monin P; Vert P; Bianchetti G; Morselli PL
Arch Fr Pediatr; 1981; 38(7):503-8. PubMed ID: 7283656
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics and clinical efficacy of indomethacin in premature infants with patent ductus arteriosus.
Regazzi MB; Rondanelli R; Vidale E; Chirico G; Rondini G; Chiara A; Piccolo A
Int J Clin Pharmacol Res; 1984; 4(2):109-12. PubMed ID: 6469435
[TBL] [Abstract][Full Text] [Related]
12. A preliminary study on pharmacokinetics of oral indomethacin in premature infants in north India.
Sharma PK; Garg SK; Narang A
Indian J Med Res; 2003 Apr; 117():164-9. PubMed ID: 14604305
[TBL] [Abstract][Full Text] [Related]
13. Oral ibuprofen in early curative closure of patent ductus arteriosus in very premature infants.
Cherif A; Jabnoun S; Khrouf N
Am J Perinatol; 2007 Jun; 24(6):339-45. PubMed ID: 17564958
[TBL] [Abstract][Full Text] [Related]
14. Disposition of indomethacin in preterm infants.
Bhat R; Vidyasagar D; Vadapalli M; Whalley C; Fisher E; Hastreiter A; Evans M
J Pediatr; 1979 Aug; 95(2):313-6. PubMed ID: 448576
[TBL] [Abstract][Full Text] [Related]
15. Early versus late indomethacin treatment for patent ductus arteriosus in premature infants with respiratory distress syndrome.
Van Overmeire B; Van de Broek H; Van Laer P; Weyler J; Vanhaesebrouck P
J Pediatr; 2001 Feb; 138(2):205-11. PubMed ID: 11174617
[TBL] [Abstract][Full Text] [Related]
16. Neonatal necrotizing enterocolitis with intestinal perforation in extremely premature infants receiving early indomethacin treatment for patent ductus arteriosus.
Fujii AM; Brown E; Mirochnick M; O'Brien S; Kaufman G
J Perinatol; 2002; 22(7):535-40. PubMed ID: 12368968
[TBL] [Abstract][Full Text] [Related]
17. Consequences of delayed surgical closure of patent ductus arteriosus in very premature infants.
Jaillard S; Larrue B; Rakza T; Magnenant E; Warembourg H; Storme L
Ann Thorac Surg; 2006 Jan; 81(1):231-4. PubMed ID: 16368371
[TBL] [Abstract][Full Text] [Related]
18. Intravenous indomethacin and changes of renal function in premature infants with patent ductus arteriosus.
John EG; Vasan U; Hastreiter AR; Bhat R; Evans MA
Pediatr Pharmacol (New York); 1984; 4(1):11-9. PubMed ID: 6739182
[TBL] [Abstract][Full Text] [Related]
19. Indomethacin therapy for patent ductus arteriosus in premature infants: efficacy of a dosing strategy based on a second-dose peak plasma indomethacin level and estimated plasma indomethacin levels.
O'Donovan DJ; Fernandes CJ; Nguyen NY; Adams K; Adams JM
Am J Perinatol; 2004 May; 21(4):191-7. PubMed ID: 15168317
[TBL] [Abstract][Full Text] [Related]
20. Renal impairment associated with indomethacin treatment for patent ductus arteriosus in extremely preterm neonates--is postnatal age at start of treatment important?
Srinivasjois RM; Nathan EA; Doherty DA; Patole SK
J Matern Fetal Neonatal Med; 2006 Dec; 19(12):793-9. PubMed ID: 17190690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
